ATE362482T1 - Rgd-sequenzen enthaltende peptido-mimetische verbindungen als integrin inhibitioren - Google Patents

Rgd-sequenzen enthaltende peptido-mimetische verbindungen als integrin inhibitioren

Info

Publication number
ATE362482T1
ATE362482T1 AT00830535T AT00830535T ATE362482T1 AT E362482 T1 ATE362482 T1 AT E362482T1 AT 00830535 T AT00830535 T AT 00830535T AT 00830535 T AT00830535 T AT 00830535T AT E362482 T1 ATE362482 T1 AT E362482T1
Authority
AT
Austria
Prior art keywords
peptido
compounds containing
integrin inhibitors
mimetic compounds
rgd sequences
Prior art date
Application number
AT00830535T
Other languages
English (en)
Inventor
Carlo Scolastico
Giuseppe Giannini
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE362482T1 publication Critical patent/ATE362482T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT00830535T 1999-08-04 2000-07-27 Rgd-sequenzen enthaltende peptido-mimetische verbindungen als integrin inhibitioren ATE362482T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/366,198 US6235877B1 (en) 1999-08-04 1999-08-04 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors

Publications (1)

Publication Number Publication Date
ATE362482T1 true ATE362482T1 (de) 2007-06-15

Family

ID=23442047

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00830535T ATE362482T1 (de) 1999-08-04 2000-07-27 Rgd-sequenzen enthaltende peptido-mimetische verbindungen als integrin inhibitioren

Country Status (10)

Country Link
US (2) US6235877B1 (de)
EP (1) EP1077218B1 (de)
JP (1) JP2001089499A (de)
KR (2) KR20010049974A (de)
AT (1) ATE362482T1 (de)
DE (1) DE60034849T2 (de)
DK (1) DK1077218T3 (de)
ES (1) ES2284469T3 (de)
PT (1) PT1077218E (de)
SI (1) SI1077218T1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2284459C (en) 1999-10-04 2012-12-11 Neokimia Inc. Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
JP4660067B2 (ja) * 2001-04-24 2011-03-30 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗血管新生剤とＴＮＦαとを用いる組合せ療法
CA2478317A1 (en) * 2002-03-04 2003-09-18 Medimmune, Inc. Methods of preventing or treating disorders by administering an integrin .alpha.v.beta.3 antagonist in combination with an hmg-coa reductase inhibitor or a bisphosphonate
WO2003075957A1 (en) * 2002-03-04 2003-09-18 Medimmune, Inc. The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
ITRM20020370A1 (it) * 2002-07-09 2004-01-09 Sigma Tau Ind Farmaceuti Composto peptido-mimetico contenente la sequenza rgd utile come inibitore delle integrine.
GB2395480A (en) * 2002-11-19 2004-05-26 Sigma Tau Ind Farmaceuti Pyrrolo[1,2-a]pyridine & pyrrolo[1,2-a]azepine scaffolds useful for the synthesis of compounds with biological activity
WO2004066956A2 (en) * 2003-01-30 2004-08-12 Medimmune, Inc. Uses of integrin alphavbeta3 antagonists
ITMI20031476A1 (it) * 2003-07-18 2005-01-19 Univ Degli Studi Milano Composti peptido-mimetici a struttura azabicicloalcanica comprendenti la sequenza rgd
ITMI20032102A1 (it) * 2003-10-30 2005-04-30 Univ Degli Studi Milano Composti peptidomimetici, procedimento stereoselettivo per la loro preparazione, loro uso come intermedi di sintesi di derivati biologicamente attivi.
CA2573644A1 (en) * 2004-07-12 2006-02-16 Idun Pharmaceuticals, Inc. Tetrapeptide analogs
WO2006048473A1 (es) * 2004-10-30 2006-05-11 Universidad Del Pais Vasco/Euskal Herriko Unibertsitatea CICLOPÉPTIDOS RGD β-LACTÁMINOS GIROS GAMMA (Ϝ)
EP2094711B8 (de) * 2006-09-25 2018-03-28 Forschungsverbund Berlin e.V. Strukturmimetika prolinreicher peptide und ihre pharmazeutische verwendung
US8084862B2 (en) 2007-09-20 2011-12-27 International Business Machines Corporation Interconnect structures with patternable low-k dielectrics and method of fabricating same
US7709370B2 (en) 2007-09-20 2010-05-04 International Business Machines Corporation Spin-on antireflective coating for integration of patternable dielectric materials and interconnect structures
US8618663B2 (en) 2007-09-20 2013-12-31 International Business Machines Corporation Patternable dielectric film structure with improved lithography and method of fabricating same
US8263133B2 (en) * 2009-02-18 2012-09-11 The Regents Of The University Of California Multivalent clustering targeting strategy for drug carriers
EP2457593A1 (de) * 2010-11-08 2012-05-30 Lykera Biomed S.A. Zyklische RGD-Peptide von Aminosäuren auf Basis von Thiazolen oder Oxazolen als selektive Antagonisten des Alpha-v beta-3-Integrins
US9339329B2 (en) 2012-09-17 2016-05-17 The Regents Of The University Of California Bladder denervation for treating overactive bladder
US11332498B2 (en) 2017-03-17 2022-05-17 Technische Universitat Munchen Ligands for integrin αVβ8, synthesis and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0527798T3 (da) 1990-04-06 1997-12-15 Jolla Cancer Res Found Fremgangsmåde og sammensætning til behandling af thrombose
AU666853B2 (en) 1991-04-05 1996-02-29 Genentech Inc. Platelet aggregation inhibitors having high specificity for GP IIbIIIa
KR100330465B1 (ko) 1993-06-11 2002-11-23 메렐 파마슈티칼스 인크. 삼관능성항트롬빈및항혈소판펩티드
WO1995000544A1 (en) 1993-06-18 1995-01-05 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5753230A (en) * 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
US5770565A (en) 1994-04-13 1998-06-23 La Jolla Cancer Research Center Peptides for reducing or inhibiting bone resorption
AU2958195A (en) * 1994-06-29 1996-01-25 Texas Biotechnology Corporation Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin
US5767071A (en) 1995-06-07 1998-06-16 Ixsys Incorporated Sevenmer cyclic peptide inhibitors of diseases involving αv β3
IT1277405B1 (it) * 1995-08-01 1997-11-10 Menarini Farma Ind Derivati di lattami biciclici come inibitori della trombina
ATE308981T1 (de) 1995-08-14 2005-11-15 Scripps Research Inst Verfahren und mittel zur hemmung der durch alpha v beta 5 vermittelten angiogenese
US5817750A (en) 1995-08-28 1998-10-06 La Jolla Cancer Research Foundation Structural mimics of RGD-binding sites
DE19653036A1 (de) * 1996-12-19 1998-06-25 Merck Patent Gmbh Cyclopeptidderivate
AU8064998A (en) 1997-06-10 1998-12-30 Du Pont Pharmaceuticals Company Fibronectin antagonists as therapeutic agents and broad-spectrum enha ncers of antibiotic therapy

Also Published As

Publication number Publication date
US6437094B2 (en) 2002-08-20
SI1077218T1 (sl) 2007-08-31
PT1077218E (pt) 2007-08-08
ES2284469T3 (es) 2007-11-16
KR20010049974A (ko) 2001-06-15
KR20070104314A (ko) 2007-10-25
DE60034849T2 (de) 2008-01-17
EP1077218A3 (de) 2001-12-19
DE60034849D1 (de) 2007-06-28
US6235877B1 (en) 2001-05-22
EP1077218B1 (de) 2007-05-16
EP1077218A2 (de) 2001-02-21
JP2001089499A (ja) 2001-04-03
DK1077218T3 (da) 2007-09-24
US20010001309A1 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
ATE362482T1 (de) Rgd-sequenzen enthaltende peptido-mimetische verbindungen als integrin inhibitioren
NL350075I2 (de)
BG106771A (en) Heterocyclic substituted pyrazolones
ATE309237T1 (de) Aromatische heterozyklische verbindungen als antientzündungwirkstoffe
BG103485A (en) Ketobanzamides as calpain inhibitors
TR200100238T2 (tr) Yeni sübstitüe edilmiş pirazol türevleri
ATE263157T1 (de) Nematizide trifluorbutene
ATE284853T1 (de) Ureido-thiobuttersäurederivate als ppar-agonisten
SE9904108D0 (sv) Nya föreningar
PL354030A1 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
YU40002A (sh) Antipikornavirusna jedinjenja i kompozicije, njihove farmaceutske upotrebe, i materijali za njihove sinteze
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
YU76500A (sh) Hemijska sinzeza morfolinskih derivata
TR199902094T2 (xx) 3-Heteroareil-4(3H)-kinazolinonlar�n atropizomerleri.
AU2001228486A1 (en) Method for cleaning off-gas flows
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.
DE69709252D1 (de) Coumarin-Derivate, Verfahren zu deren Herstellung und deren Verwendung
DE69906243T2 (de) 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
TR200100435T1 (tr) Optik yönden aktif olan alfa-aminonitrillerin hazırlanmasına yönelik yeni metod.
YU22802A (sh) Izonipekotamidi za lečenje poremećaja nastalih posredstvom integrina
TR200400907T4 (tr) Beta D 5-Tiyoksiloz türevleri, bunları hazırlama yöntemi ve bunların terapötik kullanımları
NO20020886L (no) Nye integrin- <alfa>v<beta>3-inhibitorer
DE60019723D1 (de) Eine methode zur herstellung von verbindungen der formel 1 und derivaten
IT1301825B1 (it) Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4-tetraidroisochinolin-3-carbossiammide.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1077218

Country of ref document: EP

REN Ceased due to non-payment of the annual fee